ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract.
The androgen receptor (AR) is a ligand-induced transcription factor and contains the polyglutamine (polyQ) tracts within its N-terminal transactivation domain. The length of polyQ tracts has been suggested to alter AR transcriptional activity in prostate cancer along with other endocrine and neurolo...
Main Authors: | Xiaomeng Li, Chunfang Zhu, William H Tu, Nanyang Yang, Hui Qin, Zijie Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3176788?pdf=render |
Similar Items
-
ZMIZ2 promotes the development of triple-receptor negative breast cancer
by: Xiaopan Zou, et al.
Published: (2022-01-01) -
An Amyloidogenic Sequence at the N-Terminus of the Androgen Receptor Impacts Polyglutamine Aggregation
by: Emmanuel Oppong, et al.
Published: (2017-06-01) -
Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction
by: Nath, Samir R., et al.
Published: (2020) -
Mechanisms mediating spinal and bulbar muscular atrophy: Investigations into polyglutamine-expanded androgen receptor function and dysfunction
by: Lenore K. Beitel, et al.
Published: (2013-05-01) -
Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis
by: N. Fewings, et al.
Published: (2017-04-01)